Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenome-wide analysis uncovers a blood-based DNA methylation biomarker of lifetime cannabis use.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 1 Apr 2021

Markunas Christina A, Hancock Dana B, Xu Zongli, Quach Bryan C, Fang Fang, Sandler Dale P, Johnson Eric O, Taylor Jack A

Abstract excerpt

Cannabis use is highly prevalent and is associated with adverse and beneficial effects. To better understand the full spectrum of health consequences, biomarkers that accurately classify cannabis use are needed. DNA methylation (DNAm) is an excellent candidate, yet no blood-based epigenome-wide association studies (EWAS) in humans exist. We conducted an EWAS of lifetime cannabis use (ever vs. never) using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Epigenesis, Genetic

Share to Epigenome

Share to Genetic Markers

Share to Genome-Wide Association Study

Share to Substance-Related Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 32803843
DOI: 10.1002/ajmg.b.32813
PMCID: PMC8296847

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenome-wide analysis uncovers a blood-based DNA methylation biomarker of lifetime cannabis use.PMID 32803843Read ↗

Genome-wide DNA methylation analysis of heavy cannabis exposure in a New Zealand longitudinal cohortSemantic proximity Read ↗

Genome-wide DNA methylation analysis of heavy cannabis exposure in a New Zealand longitudinal cohortSemantic proximity Read ↗

Genome-wide DNA methylation association study of recent and cumulative marijuana use in middle aged adultsSemantic proximity Read ↗

Genome-wide DNA methylation differences in nucleus accumbens of smokers vs. nonsmokersSemantic proximity Read ↗

A DNA methylation biomarker of alcohol consumptionSemantic proximity Read ↗

Genome-wide association studies of lifetime and frequency cannabis use in 131,895 individualsSemantic proximity Read ↗

A DNA methylation biomarker of alcohol consumptionSemantic proximity Read ↗

Cis-meQTL for cocaine use-associated DNA methylation in an HIV-positive cohort show pleiotropic effects on multiple traits.Semantic proximity Read ↗

Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis ConsortiumSemantic proximity Read ↗

Genome-wide association study identifies a novel locus for cannabis dependence.Semantic proximity Read ↗

Association of prenatal exposure to opioids, cannabis, and polysubstance use with cord blood DNA methylation patterns in a multiancestry cohortSemantic proximity Read ↗

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.